These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 25816912)
1. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation. Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912 [TBL] [Abstract][Full Text] [Related]
2. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential. Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307 [TBL] [Abstract][Full Text] [Related]
3. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice. Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129 [TBL] [Abstract][Full Text] [Related]
4. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171 [TBL] [Abstract][Full Text] [Related]
5. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist. Endoh T; Matsuura H; Tajima A; Izumimoto N; Tajima C; Suzuki T; Saitoh A; Suzuki T; Narita M; Tseng L; Nagase H Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186 [TBL] [Abstract][Full Text] [Related]
6. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats. Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664 [TBL] [Abstract][Full Text] [Related]
7. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist. Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155 [TBL] [Abstract][Full Text] [Related]
9. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice. Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510 [TBL] [Abstract][Full Text] [Related]
10. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice. Bhalla S; Zhang Z; Patterson N; Gulati A Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944 [TBL] [Abstract][Full Text] [Related]
11. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287 [TBL] [Abstract][Full Text] [Related]
12. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
13. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor. Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137 [TBL] [Abstract][Full Text] [Related]
14. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability. Yi SP; Kong QH; Li YL; Pan CL; Yu J; Cui BQ; Wang YF; Wang GL; Zhou PL; Wang LL; Gong ZH; Su RB; Shen YH; Yu G; Chang KJ Acta Pharmacol Sin; 2017 Jul; 38(7):977-989. PubMed ID: 28502978 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist. Wang YH; Chai JR; Xu XJ; Ye RF; Zan GY; Liu GY; Long JD; Ma Y; Huang X; Xiao ZC; Dong H; Wang YJ Sci Rep; 2018 Sep; 8(1):14087. PubMed ID: 30237513 [TBL] [Abstract][Full Text] [Related]
16. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice. Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907 [TBL] [Abstract][Full Text] [Related]